1. India Stocks

  2. •

    Health services

  3. •

    Medical/Nursing services
Suraksha Diagnostic Ltd.

Suraksha Diagnostic Ltd.

299.35
INR
+10.40
(+3.60%)
6.74EPS
39.67P/E
14.22BMarket Cap
Nov 14Next Earn
Suraksha Diagnostic Ltd.
NSE:SURAKSHA
(National Stock Exchange of India)

Recent

price

299.35

P/E

ratio

39.67

div

yld

- -

ROIC.AI

2022
2023
2024
2025
2026
TTM
INR
42.86
36.51
41.99
48.4
59.6
62.55
Revenue per Share
4
1.25
4.54
6.11
6.18
6.88
Basic EPS, GAAP
7.41
5.94
2.88
4.1
2.78
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
Dividend per Share
27.69
29.63
34.14
40.56
47.01
- -
Book Value per Share
27.35
29.35
33.93
40.18
45.7
- -
Tangible Book Value per Share
52
52
52
52
52
52
Basic Weighted Avg Shares
2,232
1,901
2,187
2,521
3,104
3,255
Sales/Revenue/Turnover
16.42
8.3
18.73
18.82
17.85
18.48
Operating Margin (%)
284
317
326
353
414
432
Depreciation Expense
208
65
236
318
322
358
Net Income, GAAP
25.66
10.12
26.47
25.18
29.52
27.85
Effective Tax Rate (%)
9.33
3.43
10.8
12.62
10.37
11
Profit Margin (%)
247
297
330
44
29
- -
Working Capital
831
804
755
741
1,143
- -
LT Debt
1,458
1,555
1,791
2,102
2,435
- -
Total Equity
- -
4.85
10.64
12.46
11.69
- -
Return on Invested Capital (%)
- -
6.07
11.72
13.69
12.43
- -
Return on Capital (%)
- -
4.37
14.23
16.36
14.11
- -
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
161
- -
LT Borrowings
- -
2
- -
LT Finance Leases
- -
1,141
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
52
52
52
Market Capitalization
14,044
11,872
14,215

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
626
- -
Cash, Cash Equivalents & STI
- -
217
- -
Accounts Receivable, Net
- -
228
- -
Inventories
- -
81
- -
Total Current Liabilities
- -
596
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
161
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
15.81%
Free Cash Flow
- -
- -
-32.11%
Net Income, GAAP
- -
- -
1.14%
Sales/Revenue/Turnover
- -
- -
23.13%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
607
668
595
651
2,521
2026
726
787
777
814
3,104
2027
876
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
1.52
1.99
1.18
1.42
6.11
2026
1.8
1.73
1.44
1.21
6.18
2027
2.5
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -
Similar Companies
Hims & Hers Health, Inc. (NYSE:HIMS)
Mobile-health Network Solutions (NASDAQ:MNDR)
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
Tenon Medical, Inc. (NASDAQ:TNON)
Teladoc Health, Inc. (NYSE:TDOC)
Business
Suraksha Diagnostic Limited operates as an integrated diagnostic services provider offering comprehensive pathology, radiology, and medical consultation services across eastern India. The company delivers over 2,300 tests encompassing routine and specialized pathology including biochemistry, hematology, histopathology, molecular biology, cytogenetics, and next-generation sequencing; advanced radiology such as X-rays, ultrasonography, CT scans, MRI, and specialized imaging; cardiology tests like electrocardiograms, echocardiograms, stress tests, and Holter monitoring; gastroenterology procedures including endoscopies and colonoscopies; as well as neurology, dental, physiotherapy, immunology, rheumatology, eye care, fetal care, ENT, and specialty clinic consultations through its polyclinics with over 1,000 doctors. It maintains a hub-and-spoke model featuring a flagship 40,000 square foot central reference laboratory in New Town, Kolkata equipped with AI-enabled robotic tracks, liquid chromatography, and mass spectroscopy; eight satellite laboratories; 49 diagnostic centers comprising 13 hub centers, 11 medium centers, 23 small centers, and two public-private partnership centers; and 166 sample collection centers primarily in West Bengal, Bihar, Assam, Meghalaya, and Delhi NCR, supported by home collection, house calls, and digital report delivery. Founded in 1992 and headquartered in Kolkata, West Bengal, Suraksha Diagnostic employs approximately 1,175 staff and utilizes equipment from leading vendors including Siemens Healthineers, Wipro GE Healthcare, Roche Diagnostics, and Beckman Coulter. Recent developments include the April 2025 acquisition of a 63% stake in Fetomat Wellness Private Limited for maternal-fetal medicine and genomic integration; the launch of Suraksha Genomics in Q1 FY26 for advanced genetic and molecular testing; addition of 11 centers in H1 FY26 with plans for three more hub and six spoke centers; a December 2024 IPO raising Rs 846.25 crore for expansion; and subsidiaries such as Suraksha Radiology Private Limited and Asian Institute of Immunology and Rheumatology LLP.